Ocugen, Inc.
BG ˙ BUL ˙ US67577C1053
SecurityBG:2H51 / Ocugen, Inc.
InstitutionCitigroup Inc
Latest Disclosed Ownership143,159 shares
Latest Disclosed Value $ 259,118
Citigroup Inc reports 40.52% increase in ownership of 2H51 / Ocugen, Inc.

On May 11, 2026 - Citigroup Inc filed a 13F-HR form disclosing ownership of 143,159 shares of Ocugen, Inc. (BG:2H51) valued at $259,118 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 101,878 shares of Ocugen, Inc.. This represents a change in shares of 40.52% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F OCUGEN COM 67577C105 143,159 41,281 40.52 259 89.05 0.0001
2026-02-13 2025-12-31 13F OCUGEN COM 67577C105 101,878 101,648 44,194.78 138 0.0001
2025-11-10 2025-09-30 13F OCUGEN COM 67577C105 230 -11,969 -98.11 0 -100.00 0.0000
2025-08-11 2025-06-30 13F OCUGEN COM 67577C105 12,199 -208,892 -94.48 12 -92.95 0.0000
2025-05-12 2025-03-31 13F OCUGEN COM 67577C105 221,091 -24,558 -10.00 156 -20.81 0.0001
2025-02-12 2024-12-31 13F OCUGEN COM 67577C105 245,649 47,918 24.23 198 0.51 0.0001
2024-11-12 2024-09-30 13F OCUGEN COM 67577C105 197,731 51,223 34.96 196 -13.66 0.0001
2024-08-12 2024-06-30 13F OCUGEN COM 67577C105 146,508 121,430 484.21 227 453.66 0.0001
2024-05-10 2024-03-31 13F OCUGEN COM 67577C105 25,078 24,914 15,191.46 41 0.0000
2024-02-09 2023-12-31 13F OCUGEN COM 67577C105 164 -581 -77.99 0 0.0000
2023-12-06 2023-09-30 13F/A-1 OCUGEN COM 67577C105 745 -151 -16.85 0 0.0000
2023-11-09 2023-09-30 13F OCUGEN COM 67577C105 745 -151 0 0.0000
2023-08-10 2023-06-30 13F OCUGEN COM 67577C105 896 -52,749 -98.33 0 -100.00 0.0000
2023-05-11 2023-03-31 13F OCUGEN COM 67577C105 53,645 -1,089,577 -95.31 46 -96.97 0.0000
2023-02-09 2022-12-31 13F OCUGEN COM 67577C105 1,143,222 -654,557 -36.41 1,486 -53.56 0.0012
2022-11-10 2022-09-30 13F OCUGEN COM 67577C105 1,797,779 352,142 24.36 3,200 -2.50 0.0023
2022-08-10 2022-06-30 13F OCUGEN COM 67577C105 1,445,637 1,036,249 253.12 3,282 142.93 0.0024
2022-05-12 2022-03-31 13F OCUGEN COM 67577C105 409,388 -422,491 -50.79 1,351 -64.31 0.0008
2022-02-10 2021-12-31 13F OCUGEN COM 67577C105 831,879 472,438 131.44 3,785 46.65 0.0020
2021-11-10 2021-09-30 13F OCUGEN COM 67577C105 359,441 -339,425 -48.57 2,581 -54.01 0.0015
2021-08-10 2021-06-30 13F OCUGEN COM 67577C105 698,866 294,657 72.90 5,612 104.44 0.0034
2021-05-13 2021-03-31 13F OCUGEN COM 67577C105 404,209 404,209 -42.16 2,745 -51.09 0.0018
2019-02-12 2018-12-31 13F HISTOGENICS COM 43358V109 0 -500 -100.00 0 0.0000
2018-11-13 2018-09-30 13F HISTOGENICS COM 43358V109 500 0 0.00 0 -100.00
2018-08-10 2018-06-30 13F HISTOGENICS COM 43358V109 500 0 0.00 1 0.00 0.0000
2018-05-11 2018-03-31 13F HISTOGENICS COM 43358V109 500 0 0.00 1 0.00 0.0000
2018-02-12 2017-12-31 13F HISTOGENICS COM 43358V109 500 -800 -61.54 1 -66.67 0.0000
2017-11-13 2017-09-30 13F HISTOGENICS COM 43358V109 1,300 0 0.00 3 50.00 0.0000
2017-08-11 2017-06-30 13F HISTOGENICS COM 43358V109 1,300 0 0.00 2 0.00 0.0000
2017-05-12 2017-03-31 13F HISTOGENICS COM 43358V109 1,300 500 62.50 2 100.00 0.0000
2017-02-10 2016-12-31 13F HISTOGENICS COM 43358V109 800 -400 -33.33 1 -75.00 0.0000
2016-11-10 2016-09-30 13F HISTOGENICS COM 43358V109 1,200 -1,450 -54.72 4 -20.00 0.0000
2016-08-12 2016-06-30 13F HISTOGENICS COM 43358V109 2,650 -100 -3.64 5 -16.67 0.0000
2016-05-13 2016-03-31 13F HISTOGENICS COM 43358V109 2,750 -500 -15.38 6 -45.45 0.0000
2016-02-12 2015-12-31 13F HISTOGENICS COM 43358V109 3,250 0 0.00 11 -15.38 0.0000
2015-11-13 2015-09-30 13F HISTOGENICS COM 43358V109 3,250 550 20.37 13 -23.53 0.0000
2015-08-13 2015-06-30 13F HISTOGENICS COM 43358V109 2,700 -500 -15.62 17 -46.87 0.0000
2015-05-14 2015-03-31 13F HISTOGENICS COM 43358V109 3,200 2,525 374.07 32 300.00 0.0000
2015-02-17 2014-12-31 13F HISTOGENICS COM 43358V109 675 675 8 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.